BioRadar Blog
Biotech trading insights, PDUFA analysis, and market intelligence.
What Happens to a Stock After FDA Approval or Rejection?
An FDA decision is one of the biggest catalysts a biotech stock faces. But the reaction is not as simple as “approval up, rejection down.” Here is what tends to…
Read article →Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Jul 26–Aug 2, 2026)
Here’s what’s on the biotech calendar for July 26–August 2: 1 FDA decision dates, 14 trial catalysts, and 1 earnings reports from tracked companies. 💊 FDA Decisions (PDUFA Dates) Date…
Read article →How the FDA Drug Approval Process Works, Step by Step
Understanding the FDA drug approval process helps investors read biotech news with more confidence and know which milestones move stocks. Here is the path a drug takes from the lab…
Read article →Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Jul 19–Jul 26, 2026)
Here’s what’s on the biotech calendar for July 19–July 26: 0 FDA decision dates, 2 trial catalysts, and 0 earnings reports from tracked companies. 🧪 Trial Catalysts & Milestones OSTX…
Read article →PDUFA Date Trading Strategy: How to Trade FDA Decisions
Trading around PDUFA dates is one of the most popular — and most dangerous — strategies in biotech. An FDA decision is close to a binary event: approval can send…
Read article →Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Jul 12–Jul 19, 2026)
Here’s what’s on the biotech calendar for July 12–July 19: 1 FDA decision dates, 3 trial catalysts, and 0 earnings reports from tracked companies. 💊 FDA Decisions (PDUFA Dates) Date…
Read article →How to Track PDUFA Dates: A Biotech Trader’s Guide
For biotech traders, PDUFA dates are the calendar that matters most. A PDUFA date is the FDA’s target action date for deciding on a drug application, and it is one…
Read article →What the Public Data Can and Cannot Tell Us About SELLAS’s Galinpepimut-S in AML
A statistical analysis of SELLAS's Phase 3 REGAL trial of galinpepimut-S (GPS) in AML — what the blinded, pooled event data can and cannot tell us.
Read article →Biotech Catalysts This Week: FDA Decisions, Readouts & Earnings (Jul 5–Jul 12, 2026)
Here’s what’s on the biotech calendar for July 5–July 12: 2 FDA decision dates, 0 trial catalysts, and 0 earnings reports from tracked companies. 💊 FDA Decisions (PDUFA Dates) Date…
Read article →Best Biotech Catalyst & FDA Calendar Tools (2026)
A fair comparison of the main biotech catalyst and FDA calendar tools in 2026 — BioPharmCatalyst, BiopharmaWatch, BPIQ, FDA Tracker and BioRadar — and how to choose.
Read article →